Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for prevention of postoperative cognitive dysfunction after cardiac surgery
ChiCTR-TRC-11001432Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lidocaine in post-operative cognitive decline (POCD) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of postoperative cognitive dysfunction. Started Jul 2003; status: completed.
02
Drugs
lidocaine
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR-TRC-11001432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001432.